Physician profile
John Litz
NPI 1295949154
$456.66
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $92.15 · 2021: $248.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $154.52 | 2020-2021 | |
| Abbvie INC. | $146.75 | 2019-2021 | |
| Allergan, INC. | $50.30 | 2019-2020 | |
| Exeltis, USA INC. | $40.07 | 2019-2021 | |
| Agile Therapeutics, INC. | $25.16 | 2021 | |
| Mayne Pharma Commercial LLC | $14.59 | 2021 | |
| Lupin INC. | $13.15 | 2019 | |
| Therapeuticsmd, INC. | $12.12 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Litz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.